List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 4863 studies with search of: "Carcinoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
Conditions: Carcinoma, Squamous Cell;   Carcinoma, Adenosquamous;   Carcinoma, Large Cell;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: CP-751,871 + Carboplatin +Paclitaxel;   Drug: Carboplatin + Paclitaxel
2 Active, not recruiting RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
Conditions: Neuroendocrine Carcinoma;   Islet Cell Carcinoma
Interventions: Drug: RAD001;   Drug: Octreotide Depot
3 Withdrawn Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
Conditions: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: capecitabine;   Procedure: adjuvant therapy;   Procedure: chemotherapy
4 Recruiting Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
5 Completed Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head and/or Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin
6 Recruiting Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer
Conditions: Carcinoma, Renal Cell;   Adenocarcinoma, Renal Cell;   Nephroid Carcinoma;   Carcinoma, Hypernephroid
Interventions: Drug: bevacizumab, RAD001(Everolimus);   Drug: bevacizumab, interferon alfa-2a
7 Terminated Two Studies to Determine If Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
Conditions: Basal Cell Carcinoma;   Nevoid Basal Cell Carcinoma Syndrome;   Gorlin Syndrome
Intervention: Drug: verteporfin PDT
8 Completed Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Advanced Squamous Cell Carcinoma;   Squamous Cell Carcinoma of Head and Neck;   SSCHN
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5-Fluorouracil
9 Completed Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head/Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: G-CSF;   Drug: Ciprofloxacin
10 Completed Celecoxib/Oxaliplatin/Capecitabine for Gastric/GE Junction Carcinoma
Conditions: Gastric Carcinoma;   Gastroesophageal Junction Carcinoma
Interventions: Drug: Oxaliplatin;   Drug: Capecitabine;   Drug: Celecoxib
11 Active, not recruiting Docetaxel, Cisplatin, 5-Fluorouracil (TPF) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)
Conditions: Squamous Cell Carcinoma of the Hypopharynx;   Larynx Carcinoma
Interventions: Radiation: Radiation;   Drug: Cetuximab;   Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5-Fluorouracil
12 Not yet recruiting Skin Cancer Prevention
Conditions: Carcinoma, Basal Cell;   Carcinoma, Squamous Cell;   Skin Neoplasms;   Skin Diseases;   Neoplasms, Basal Cell;   Neoplasms, Squamous Cell;   Carcinoma
Interventions: Drug: 5-fluorouracil;   Drug: Placebo, vehicle control
13 Terminated Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
Conditions: Primary Advanced Carcinoma of the Oral Cavity or Oropharynx;   Squamous Cell Carcinoma of the Head and Neck
Intervention: Biological: autologous monocyte-derived dendritic cells (DC) transfected with DNA
14 Recruiting Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma
Conditions: Recurrent Colorectal Carcinoma;   Progressive Colorectal Carcinoma
Interventions: Biological: Safety and efficacy of escalating doses;   Biological: Safety and efficacy of escalating doses.
15 Active, not recruiting Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer
Conditions: Skin Cancer;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Intervention:
16 Recruiting PRISM (Panitumumab Regimen In Second-Line Monotherapy of Head and Neck Cancer)
Conditions: Cancer;   Carcinoma;   Head and Neck Cancer;   Metastases;   Metastatic Cancer;   Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck;   Oncology;   Squamous Cell Carcinoma;   Tumors
Intervention: Drug: Panitumumab
17 Recruiting Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell;   Carcinoma, Non-Small-Cell Lung
Intervention:
18 Recruiting An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037
Conditions: Lung Cancer;   Squamous Cell Carcinoma;   Head and Neck Cancer;   Hepatic Carcinoma;   Renal Cell Carcinoma
Intervention: Drug: [F-18] VM4-037
19 Withdrawn Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Conditions: Merkel Cell Carcinoma;   Islet Cell Carcinoma;   Neuroendocrine Carcinoma;   Pituitary Tumor
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy
20 Recruiting The Impact of Total Body Skin Examination on Skin Cancer Detection
Conditions: Melanoma;   Basal Cell Carcinoma;   Squamous Cell Carcinoma;   Merkel Cell Carcinoma;   Skin Cancer
Intervention: Other: skin cancer detection rate (Total Body Skin Examination)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services